SYRE
Price:
$33.51
Market Cap:
$2.02B
Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is also developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; S...[Read more]
Industry
Biotechnology
IPO Date
2016-04-07
Stock Exchange
NASDAQ
Ticker
SYRE
According to Spyre Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Spyre Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SYRE's Dividend Yield was at its highest in in the December 2015 quarter at 0%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Spyre Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Spyre Therapeutics, Inc. (SYRE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Spyre Therapeutics, Inc.’s Dividend Yield is less than Pharvaris N.V. (0%), less than Immunome, Inc. (0%), less than Wave Life Sciences Ltd. (0%), less than Intellia Therapeutics, Inc. (0%), less than Zymeworks Inc. (0%), less than Maze Therapeutics, Inc. (0%), less than AbCellera Biologics Inc. (0%), less than Upstream Bio, Inc. (0%), less than Ardelyx, Inc. (0%), less than Celldex Therapeutics, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $1.80B | |
| 0% | $1.84B | |
| 0% | $1.25B | |
| 0% | $1.02B | |
| 0% | $1.99B | |
| 0% | $2.05B | |
| 0% | $1.09B | |
| 0% | $1.50B | |
| 0% | $1.42B | |
| 0% | $1.97B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spyre Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spyre Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Spyre Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Spyre Therapeutics, Inc. (SYRE)?
What is the highest Dividend Yield for Spyre Therapeutics, Inc. (SYRE)?
What is the 3-year average Dividend Yield for Spyre Therapeutics, Inc. (SYRE)?
What is the 5-year average Dividend Yield for Spyre Therapeutics, Inc. (SYRE)?
How does the current Dividend Yield for Spyre Therapeutics, Inc. (SYRE) compare to its historical average?